Risk assessment of central nervous system diseases such as Alzheimer's disease (Alzheimer's disease), stroke, and white matter lesions
It is an artificial intelligence diagnostic and analysis platform focused on central nervous system diseases. Based on the self built whole brain structure image database of the Chinese population of all ages, combined with cutting-edge big data analysis and core technologies such as artificial intelligence, it quickly and accurately assesses changes in whole brain structure, white matter lesions, microbleeding lesions, and cerebral blood flow, with quantitative and intuitive results, Assist clinical practice in making ultra early accurate diagnosis and disease progression prediction.
The operator only needs three simple steps to easily obtain a high-precision AI assisted diagnosis plan for diseases within 15 minutes, including comprehensive analysis of brain tissue volume, degree of atrophy, lesion location, etc. For doctors, the platform can provide quantitative analysis reports on brain imaging structural indicators, and for patients, the platform can provide risk assessment reports for multiple diseases of the central nervous system.